Predictors of response for elagolix with add-back therapy in women with heavy menstrual bleeding associated with uterine fibroids
Open Access
- 20 July 2020
- journal article
- research article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 224 (1) , 72.e1-72.e50
Abstract
No abstract availableKeywords
Funding Information
- AbbVie
This publication has 34 references indexed in Scilit:
- Growth factors and myometrium: biological effects in uterine fibroid and possible clinical implicationsHuman Reproduction Update, 2011
- Uterine LeiomyomasObstetrics & Gynecology, 2011
- Menstrual blood loss measurement: validation of the alkaline hematin technique for feminine hygiene products containing superabsorbent polymersFertility and Sterility, 2010
- BMI and Uterine SizeInternational Journal of Gynecological Pathology, 2010
- New Directions in the Epidemiology of Uterine FibroidsSeminars in Reproductive Medicine, 2010
- Submucosal uterine leiomyomas have a global effect on molecular determinants of endometrial receptivityFertility and Sterility, 2010
- Influence of Body Size and Body Fat Distribution on Risk of Uterine Leiomyomata in U.S. Black WomenEpidemiology, 2005
- Reproductive Factors, Hormonal Contraception, and Risk of Uterine Leiomyomata in African-American Women: A Prospective StudyAmerican Journal of Epidemiology, 2004
- Self-reported heavy bleeding associated with uterine leiomyomataObstetrics & Gynecology, 2003
- Leiomyoma-related bleeding: a classic hypothesis updated for the molecular eraHuman Reproduction Update, 1996